期刊文献+

甲基强的松龙治疗儿童手足口病临床疗效观察 被引量:3

Effect of methylprednisolone on hand-foot-and-mouth disease
暂未订购
导出
摘要 目的探讨甲基强的松龙治疗手足口病的疗效。方法将200例手足口病患儿随机分为观察组(甲基强的松龙+利巴韦林+维生素C)、对照组(利巴韦林+维生素C)。观察两组患儿的发热时间、主动进食时间、口腔溃疡愈合时间、皮疹结痂时间和药物的不良反应。结果观察组患儿退热时间、主动进食时间短于对照组,差异有统计学意义(P<0.05)。口腔溃疡愈合时间、皮疹结痂时间组间比较差异无统计学意义(P>0.05)。两组用药后均未发现有不良反应。结论短期应用甲基强的松龙治疗儿童手足口病可以缩短发热时间、提早主动进食时间,不延长病程,使用安全。 Objective To observe the therapeutic effect of methylprednisolone in the treatment of hand-foot-and-mouth disease (HFMD). Methods Two hundred children with HFMD were equally divided into the study group and the control group, with 100 cases in each group. The study group was given methylprednisolone, riba- virin and vitamin C, while the control group was given ribavirin and vitamin C. The time of defervescence, active feed- ing, ulcer healing, and skin rash retrogression were investigated. Results The time of defervescence and active feed- ing in the study group was shorter than that in the control group, with statistically significant difference (P〈0.05). The time of ulcer healing and skin rash retrogression between the two groups showed no statistically significant difference. Conclusion Methylprednisolone is effective to treat HFMD.
出处 《海南医学》 CAS 2013年第10期1524-1525,共2页 Hainan Medical Journal
关键词 手足口病 甲基强的松龙 治疗 Hand-foot-and-mouth disease (HFMd) Methylprednisolone Therapy
  • 相关文献

参考文献4

二级参考文献36

  • 1王芳,王晓川.药物性皮炎120例临床分析[J].中国麻风皮肤病杂志,2004,20(5):452-453. 被引量:2
  • 2梅小平,吴晓华,曾跃,敬雪明,李健.流行性乙型脑炎患儿脑脊液及血清中细胞因子的动态变化[J].寄生虫病与感染性疾病,2006,4(4):195-196. 被引量:4
  • 3董晓楠,应剑,陈应华.1970~2004年全球肠道病毒71型分离株的分子流行病学分析[J].科学通报,2007,52(9):1021-1027. 被引量:108
  • 4Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Euterovirus Epidemic-Working Group. N Engl J Med, 1999, 341:929-935.
  • 5Chang LY, Hsia SH, Wu CT, et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J, 2004, 23:327-332.
  • 6Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis, 2000,31:678- 683.
  • 7Lin TY, Chang LY, Huang YC, et al. Different prointlammatory reactions in fatal and non-fatal enteroviras 71 infections: implications for early recognition and therapy. Acta Paediatr, 2002,91:632-635.
  • 8Chart KP, Goh KT, Chong CY, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis, 2003, 9:78-85.
  • 9Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/ herpangina in children during an epidemic in Taiwan. Pediatrics, 2002,109 : e88.
  • 10Cheng I. Y, Hsia S H, Wu C T, et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002[J]. Pediatr Infect Dis J,2004,23(4):327-332.

共引文献152

同被引文献26

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部